We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
VLP Therapeutics announced the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for a clinical trial of the Company's VLPM01 malaria vaccine....
The new grant from the GHIT Fund will further development of processes to move the vaccine from the experimental stage to human trials and, ultimately, a clinical treatment.